Kai Hilpert
St George's, University of London
H-index: 36
Europe-United Kingdom
Top articles of Kai Hilpert
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Redefining Peptide 14D: Substitutional Analysis for Accelerated TB Diagnosis and Enhanced Activity against Mycobacterium tuberculosis | Microorganisms | Kai Hilpert Tulika Munshi Paula M López-Pérez Joana Sequeira-Garcia Tim J Bull | 2024/1/16 |
BioSAXS | Christoph Rumancev Axel Rosenhahn Kai Hilpert | 2023/8/23 | |
Can BioSAXS detect ultrastructural changes of antifungal compounds in Candida albicans?–an exploratory study | Frontiers in Pharmacology | Kai Hilpert Christoph Rumancev Jurnorain Gani Dominic WP Collis Paula Matilde Lopez-Perez | 2023/7/18 |
Specific Cationic Antimicrobial Peptides Enhance the Recovery of Low-Load Quiescent Mycobacterium tuberculosis in Routine Diagnostics | International Journal of Molecular Sciences | Tim J Bull Tulika Munshi Paula M Lopez-Perez Andy C Tran Catherine Cosgrove | 2023/12/16 |
Discovery of Antimicrobial Peptides That Can Accelerate Culture Diagnostics of Slow-Growing Mycobacteria Including Mycobacterium tuberculosis | Microorganisms | Kai Hilpert Tulika Munshi Paula M López-Pérez Joana Sequeira-Garcia Sven Hofmann | 2023/9/2 |
In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus | npj Biofilms and Microbiomes | Linda B Oyama Hamza Olleik Ana Carolina Nery Teixeira Matheus M Guidini James A Pickup | 2022/7/14 |
BioSAXS–an emerging method to accelerate, enrich and de-risk antimicrobial drug development | Christoph Rumancev Axel Rosenhahn Kai Hilpert | 2022/8/23 | |
Is there a connection between gut microbiome dysbiosis occurring in COVID-19 patients and post-COVID-19 symptoms? | Frontiers in Microbiology | Kai Hilpert Ralf Mikut | 2021/8/21 |
Comparison of a short linear antimicrobial peptide with its disulfide-cyclized and cyclotide-grafted variants against clinically relevant pathogens | Microorganisms | Johannes Koehbach Jurnorain Gani Kai Hilpert David J Craik | 2021/6/8 |
Rational designed hybrid peptides show up to a 6-fold increase in antimicrobial activity and demonstrate different ultrastructural changes as the parental peptides measured by … | Frontiers in Pharmacology | Kai Hilpert Jurnorain Gani Christoph Rumancev Nathan Simpson Paula Matilde Lopez-Perez | 2021/12/3 |
Antimicrobial Activity Of A Histone Derived Peptide In The Airway Surface Liquid | The FASEB Journal | Matthew Biggart Kai Hilpert Robert Tarren Deborah Baines | 2021/5 |
Peptides in COVID-19 clinical trials—A snapshot | Kai Hilpert | 2021/10/14 | |
Is the gut microbiome a target for adjuvant treatment of COVID-19? | Kai Hilpert | 2021/9/30 | |
Peptide inhibitors of bacterial protein synthesis with broad spectrum and SbmA-independent bactericidal activity against clinical pathogens | Journal of medicinal chemistry | Mario Mardirossian Riccardo Sola Bertrand Beckert Erica Valencic Dominic WP Collis | 2020/7/29 |
Acceleration of Mycobacterium growth | 2020/4/28 | ||
Identification Of A Novel Histone Derived Antimicrobial Peptide In Airway Surface Liquid. | The FASEB Journal | Matthew Guy Stevenson Biggart Xie Ling Nathan Simpson Jurnorain Gani John Wrobel | 2020/4 |
Are the Consequences of Gastrointestinal Infections of SARS-CoV-2 Underestimated? | Infectious Diseases and Therapeutics | K Hilpert | 2020/8/18 |
The effect of lipidation and glycosylation on short cationic antimicrobial peptides | Biochimica et Biophysica Acta (BBA)-Biomembranes | Elizabeth Grimsey Dominic WP Collis Ralf Mikut Kai Hilpert | 2020/8/1 |
Co-Authors
